for Journals by Title or ISSN
for Articles by Keywords
help
Journal Cover EJRR - European Journal of Risk Regulation
   [4 followers]  Follow    
   Full-text available via subscription Subscription journal
     ISSN (Print) 1867-299X
     Published by Lexxion Verlagsgesellschaft Homepage  [12 journals]
  • In the Aftermath of the “Myriad Case” - Myriad Is Denied
           Preliminary Injunction Against ...
    • Abstract: EJRR 3 2014 Case Notes 407
      In the Aftermath of the “Myriad Case” - Myriad Is Denied
      Preliminary Injunction Against Ambry Genetics
      Emanuela Gambini*
      On March 10, 2014, the U.S. District Court of Utah, Central Division, decided in University of
      Utah Research Foundation, et al., v. Ambry Genetics Corporation, holding that “Plaintiffs are
      not entitled to a preliminary injunction”, as they “are unable to establish that they are likely
      to succeed on the mer
      PubDate: Wed, 05 Nov 2014 11:31:41 +010
       
  • Book Reviews
    • Abstract: EJRR 3 2014 Book Reviews 413
      Book Reviews
      The Book Reviews section will introduce you to the latest and most interesting books on a wide range
      of topics pertaining to the lawand policy of risk regulation. EJRR Book Reviewswill strive to be present
      in every edition and will accept reviews from all disciplines. For further information on the submission
      of reviews please contact the Book Reviews Editor at wirajendi@lexxion.eu.
      PubDate: Wed, 05 Nov 2014 10:57:24 +010
       
  • Is 142 Euro Equal to 350 000 Euro? The CJEU Interpretation of
           “Personal Injury” and ...
    • Abstract: EJRR 3 2014 Case Notes 399
      Is 142 Euro Equal to 350 000 Euro? The CJEU Interpretation of
      “Personal Injury” and “Injured Party” in EU Motor Insurance Law
      Vadim Mantrov*
      Case C-277/12, Vitālijs Drozdovs v Baltikums AAS, Judgment of 24 October
      2013, nyr.
      Case C-22/12, Katarína Haasová v Rastislav Petrík, Blanka Holingová, Judgment
      of 24 October 2013, nyr.
      In reviewing two similar cases, the CJEU clarified several essential elements of EU motor in
      PubDate: Wed, 05 Nov 2014 10:56:14 +010
       
  • Google Spain v. González: Did the Court Forget about Freedom of
           Expression?
    • Abstract: EJRR 3 2014 Case Notes 389
      Case Notes
      Google Spain v. González: Did the Court Forget about Freedom
      of Expression?
      Case C-131/12 Google Spain SL and Google Inc. v. Agencia Española de
      Protección de Datos and Mario Costeja González
      Stefan Kulk*and Frederik Zuiderveen Borgesius**
      I. Introduction
      When reviewing a job application letter, going on a
      first date, or considering doing business with someone,
      the first thing many people do is entering t
      PubDate: Wed, 05 Nov 2014 10:53:43 +010
       
  • Risk Communication: Challenges and Opportunities of Omnichannel Retailing
    • Abstract: 386 Reports EJRR 3 2014
      Risk Communication
      This section discusses issues related to risk communication across a range of publicly perceived
      high risk industries (such as pharmaceuticals, nuclear, oil, etc.). It reports critically and provides
      analysis on risk communication as an outcome of risk research within these industries. Contributions
      are intended to includemethods working towards the advancement of risk perception research
      and describe any lessons learned fo
      PubDate: Wed, 05 Nov 2014 10:51:10 +010
       
  • Pharmaceuticals: Assessing the Commercial Success of a Pharmaceutical
           Product Covered by a Patent
    • Abstract: 380 Reports EJRR 3 2014
      Pharmaceuticals
      This section updates readers on the latest developments in pharmaceutical law, giving information
      on legislation and case law on variousmatters (such as clinical and pre-clinical trials, drug approval
      and marketing authorisation, the role of regulatory agencies) and providing analysis on how and
      to what extent they might affect health and security of the individual as well as in industry.
      Assessing the Commercial Success of a
      PubDate: Wed, 05 Nov 2014 10:43:30 +010
       
  • Lifestyle Risks: Risk Regulation and Behaviour among Consumers of Alcohol,
           Drugs and Nicotine
    • Abstract: 374 Reports EJRR 3 2014
      Lifestyle Risks
      Risk Regulation and Behaviour among Consumers of Alcohol, Drugs
      and Nicotine
      Andy Stonard*
      This report is suggesting that some of themajor foundations
      that the regulation of alcohol, tobacco and
      nicotine, prescription drugs and illicit drugs is built
      on give serious cause for concern.
      This concern is that the science that regulation is
      based on, is interpreted differently around the
      World; some of the
      PubDate: Wed, 05 Nov 2014 10:40:20 +010
       
  • Intellecutal Property: The Draft Trans-Pacific Partnership Agreement and
           its Implications for ...
    • Abstract: 366 Reports EJRR 3 2014
      Intellecutal Property
      The Draft Trans-Pacific Partnership Agreement and its Implications
      for Public Health and Access to Medicines: The UNITAID Report
      Stefano Barazza*
      This report provides an overview of the potential impact of the draft Trans-Pacific Partnership
      Agreement on public health and access to medicines, in light of a recent analysis conducted
      by UNITAID. The international organization observed that the increased intellectual
      PubDate: Wed, 05 Nov 2014 10:39:05 +010
       
  • Food: European Commission Proposes to Revise the EU’s Legislative
           Framework on Novel Foods ...
    • Abstract: 362 Reports EJRR 3 2014
      Food
      This section aims at updating readers on the latest developments of risk-related aspects of food law
      at the EU level, giving information on legislation and case law on various matters, such as food safety,
      new diseases, animal health and welfare and food labelling.
      European Commission Proposes to Revise the EU’s Legislative
      Framework on Novel Foods and Animal Cloning
      Ignacio Carreño*
      I. Introduction
      On 18 December 2013,
      PubDate: Wed, 05 Nov 2014 10:37:08 +010
       
  • Biotechnology: Opt-out Clause in the Cultivation of GMOs is closer (or
           not)
    • Abstract: EJRR 3 2014 Reports 359
      Reports
      This part of the EJRR hosts reports in which our correspondents keep readers up to date on the most
      recent developments in different areas of risk regulation. Our aim is to fuel the debate and trigger future
      research on cutting-edge risk subjects. The Reports are organised under different policy sections.
      Further sections will be added at regular intervals. If you are interested in contributing to any of the
      existing sections, please
      PubDate: Wed, 05 Nov 2014 10:35:57 +010
       
  • Chemical Control Policy in Sweden, What is Next?
    • Abstract: 338 PIP Breast Implants and Market Surveillance by Notified Bodies EJRR 3 2014
      PIP Breast Implants, the EU’s New Approach
      for Goods and Market Surveillance by Notified
      Bodies
      Barend van Leeuwen*
      With the New Approach for goods, the EU has created a regulatory framework for placing
      products on the market in which both public and private parties have an important role to
      play. The various cases which have been brought after the PIP breast implants scandal show
      PubDate: Wed, 05 Nov 2014 10:31:35 +010
       
  • PIP Breast Implants, the EU’s New Approach for Goods and Market
           Surveillance by Notified Bodies
    • Abstract: 338 PIP Breast Implants and Market Surveillance by Notified Bodies EJRR 3 2014
      PIP Breast Implants, the EU’s New Approach
      for Goods and Market Surveillance by Notified
      Bodies
      Barend van Leeuwen*
      With the New Approach for goods, the EU has created a regulatory framework for placing
      products on the market in which both public and private parties have an important role to
      play. The various cases which have been brought after the PIP breast implants scandal show
      PubDate: Wed, 05 Nov 2014 10:30:28 +010
       
  • EU Risk Regulators and EU Procedural Law
    • Abstract: 324 EU Risk Regulators and EU Procedural Law EJRR 3 2014
      EU Risk Regulators and EU Procedural Law
      Merijn Chamon*
      Before the Treaty of Lisbon, EU agencies were unknown in the EU’s primary law defined procedural
      law. Today, following (i) the Treaty’s entry into force, (ii) the Common Approach on
      Decentralised Agencies and (iii) the European Court of Justice’s ruling in Short-selling it is
      interesting to take a look at the peculiar position of EU agencies under t
      PubDate: Wed, 05 Nov 2014 10:28:15 +010
       
  • Better Use of Science for Better EU Regulation
    • Abstract: 314 Symposium on the European Commission’s Chief Scientific Advisor EJRR 3 2014
      Better Use of Science for Better EU Regulation
      Lorna Schrefler and Jacques Pelkmans*
      Risk regulation is a major task of the EU. In this context, scientific knowledge and advice is
      critical to the preparation, formulation, legislation and later revision of EU risk regulation.
      However and with some notable exceptions (e.g. some EU Agencies, DG SANCO), there seems
      to be no systematic view
      PubDate: Wed, 05 Nov 2014 10:26:47 +010
       
  • Better Risk Regulation Governance for a Stronger Europe
    • Abstract: EJRR 3 2014 Symposium on the European Commission's Chief Scientific Advisor 309
      Better Risk Regulation Governance for a
      Stronger Europe
      The Institutionalisation of the EU Chief Scientific Adviser Office
      Dirk Hudig*
      The start of a new European Commission represents a unique opportunity to build on
      successful regulatory reforms and to create the institutional architecture needed to ensure
      that high quality scientific evidence is used effectively in EU decision-ma
      PubDate: Wed, 05 Nov 2014 10:24:44 +010
       
  • Dealing with the Challenge of Evidence-based Decision-making in Situations
           of Uncertainty and ...
    • Abstract: EJRR 3 2014 Symposium on the European Commission’s Chief Scientific Advisor 303
      Dealing with the Challenge of Evidence-based
      Decision-making in Situations of Uncertainty
      and Emergency
      Marie-Valentine Florin*
      Collection and provision of scientific information for policy and decision-making is particularly
      important during emergencies or when uncertainty and ambiguity creates situation
      of fear and anxiety. This article offers two suggestions for addressing natu
      PubDate: Wed, 05 Nov 2014 10:23:33 +010
       
  • The Role of Science in 21st Century EU Policy- Making
    • Abstract: 300 Symposium on the European Commission's Chief Scientific Advisor EJRR 3 2014
      The Role of Science in 21st Century EU Policy-
      Making
      Julie Girling*
      Today,more than ever, citizens expect value formoney,
      not only from their elected representatives, but
      also from the laws and regulations passed to protect
      them. As the European economy faces continued
      challenges and limited economic growth, citizens rely
      on policy-makers to encourage innovation and

      PubDate: Wed, 05 Nov 2014 10:22:32 +010
       
  • The Past, Present and Future of the Chief Scientific Advisor
    • Abstract: EJRR 3 2014 Symposium on the European Commission’s Chief Scientific Advisor 293
      The Past, Present and Future of the Chief
      Scientific Advisor
      James Wilsdon*
      At the end of August 2014, scientists and policymakers
      from forty-eight countries gathered at the Heritage
      Hotel in Auckland, New Zealand to debate the
      science and art of scientific advice.1 Jointly hosted by
      Sir Peter Gluckman, chief scientific advisor to the
      PrimeMinister of NewZealand, and the
      PubDate: Wed, 05 Nov 2014 10:20:58 +010
       
  • What Role – if any – for a Chief Scientist in the European
           Union System for Scientific Advice?
    • Abstract: 286 Symposium on the European Commission’s Chief Scientific Advisor EJRR 3 2014
      What Role – if any – for a Chief Scientist in
      the European Union System for Scientific
      Advice?
      Alberto Alemanno*
      At a time of increasing recognition worldwide of the role of Chief Science Advisers as of critical
      importance in improving dialogue between science and policy, the European Union, notably
      the European Commission, is currently considering – under the pressure of ci
      PubDate: Wed, 05 Nov 2014 10:19:32 +010
       
  • Editorial
    • Abstract: EJRR 3 2014 Editorial 283
      Editorial
      By focusing on the interactions between science, policy and law, the European Journal
      of Risk Regulation has always been interested in exploring the role of scientific advice
      in policymaking. While we have published several contributions discussing the
      role of expertise in both policymaking, through the analysis of EU agencies and adjudication,
      we have never had the opportunity to perform a broader analysis discussing
      the var
      PubDate: Wed, 05 Nov 2014 10:18:01 +010
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014